ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -29.3% | 3,500 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $92 | -10.7% | 3,554 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $103 | -2.8% | 3,575 | -0.3% | 0.00% | -20.0% |
| Q4 2022 | $106 | -99.9% | 3,587 | -9.0% | 0.01% | +25.0% |
| Q3 2022 | $94,000 | -5.1% | 3,941 | -11.6% | 0.00% | +33.3% |
| Q2 2022 | $99,000 | -10.0% | 4,456 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $110,000 | -39.2% | 4,399 | -12.9% | 0.00% | -25.0% |
| Q4 2021 | $181,000 | -15.4% | 5,049 | +0.6% | 0.00% | -20.0% |
| Q3 2021 | $214,000 | -5.7% | 5,020 | -4.2% | 0.01% | +25.0% |
| Q2 2021 | $227,000 | -37.6% | 5,240 | -41.3% | 0.00% | -42.9% |
| Q1 2021 | $364,000 | +111.6% | 8,921 | +134.5% | 0.01% | +75.0% |
| Q4 2020 | $172,000 | +27.4% | 3,804 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $135,000 | -6.2% | 3,804 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $144,000 | – | 3,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |